BofA lowered the firm’s price target on Rollins (ROL) to $42.30 from $49 and keeps a Buy rating on the shares ahead of the company reporting Q3 results on Oct 26. While the firm is lowering estimates “slightly” following peer Rentokil’s (RTO) miss, it calls the “big pullback” in Rollins shares a “rare opportunity to buy a high-quality compounder.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ROL: